Many years of research and in vitro production form the basis for the ongoing development of new varieties with specific properties and active ingredients.
Who we are
and our primary area of focus
We are specialised in the cloning and breeding of hemp plants under high-tech conditions. Thanks to many years of basic research, we have successfully achieved in vitro propagation of cannabis plants.
This complex procedure guarantees that sterile and virus-free hemp plants can be produced without the use of any pesticides. Quality control and order analysis of the hemp plants are also undertaken in the laboratory under exacting technical standards.
have made it their mission to research and analyse cannabis for medical purposes.
Alexander Kristen has been managing the company Flowery Field since 2004. The company has been specialised in clone research and in vitro propagation of hemp plants for more than ten years. It is currently producing 25,000 hemp plants per week under laboratory conditions.
Ao. Univ.-Prof. Dr. Rainer Schmid
Head of the analysis and quality laboratory
Chemist and toxicologist Rainer Schmid was head of toxicology and medication analytics at Vienna General Hospital and was actively involved in drug prevention in the area of recreational drugs and their mode of action and dangers.
DDr. Lisi Xie
Head of clone research and variety development
The agronomist is specialised in the area of plant physiology, molecular biology and genetics. She is proficient in numerous biological research methods ranging from microscopy techniques and tissue culture through to plant hybrids and next-generation sequencing.
We blog about current information relating to medicinal cannabis and clone research. Since we like to know about backgrounds, we continually conduct interviews with doctors, pharmacists, agronomists and researchers, who are contributing to the progress of cannabinoids in medicine by means of their results.
(Deutsch) Wir haben mit Univ.-Prof. Dr. Otto Lesch, Facharzt für Psychiatrie und Psychotherapie, Board Member der International Academy of Law and Mental Health und Präsident der Österreichischen Gesellschaft für Suchtmedizin, über die klinische Datenlage zur Wirksamkeit von Cannabis, häufige Cannabismythen und die Folgen einer gescheiterten Verbotspolitik gesprochen.
Die Cookie-Einstellungen auf dieser Website sind auf "Cookies zulassen" eingestellt, um das beste Surferlebnis zu ermöglichen. Wenn du diese Website ohne Änderung der Cookie-Einstellungen verwendest oder auf "Akzeptieren" klickst, erklärst du sich damit einverstanden.